Dear Colleagues:

The biotech industry is growing rapidly in China, partly as a result of increasing trends in offshoring and collaborations with Western companies. Despite the many advantages, however, Western biopharmaceutical companies offshoring in China must address several important issues.

Our article in the April 2009 global issue of The Monitor ACRP discusses these challenges, including the most common issues: Is there adequate IP protection in China? What measures are being taken by the government to eliminate manufacturing problems? How can foreign companies working in China overcome the major language and cultural hurdles?

The article entitled "The Future of Biotech in China: Will China Overcome its Barriers?" discusses the risks and benefits of offshoring in China, and provides insight into potential solutions. We hope you take this opportunity to read the attached article The Future of Biotech in China.pdf.

We have extensive experience in Asia and have been providing translation services to companies interested in working in China for over a decade. In order to help you effectively communicate with your clients, Language Connections employs expert translators and interpreters who are native speakers and know how to implement successful localization strategies.

We welcome any inquiries or comments you may have regarding the article or our services.


Best regards,